PR Newswire | Nov 9, 2021 04:16PM EST

11/09 15:15 CST

Jazz Pharmaceuticals to Participate in Upcoming November Investor ConferencesJefferies London Healthcare Conference4th Annual Evercore ISI HealthCONx Conference DUBLIN, Nov. 9, 2021

DUBLIN, Nov. 9, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will virtually participate in the following upcoming investor conferences:

Jefferies London Healthcare Conference on Tuesday, November 16, 2021

* The presentation is scheduled for 11:20 - 11:55 a.m. ET / 4:20 - 4:55 p.m. GMT

Evercore ISI HealthCONx Conference on Tuesday, November 30, 2021

* The presentation is scheduled for 2:40 - 3:25 p.m. ET / 7:40 - 8:25 p.m. GMT

Jazz will virtually participate in both conferences and webcasts of the presentations will be available via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharma.com. Replays of the webcasts will be available on the website for 30 days.

About Jazz PharmaceuticalsJazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases-often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharma.com and follow @JazzPharma on Twitter.

Contacts:

Investors:Andrea N. Flynn, Ph.D.Vice President, Head, Investor RelationsJazz Pharmaceuticals plcInvestorInfo@jazzpharma.comIreland +353 1 634 3211U.S. +1 650 496 2717

Media:Kristin BhavnaniHead of Global Corporate CommunicationsJazz Pharmaceuticals plcCorporateAffairsMediaInfo@jazzpharma.comIreland +353 1 697 2141U.S. +1 215 867 4948

View original content to download multimedia: https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-november-investor-conferences-301420266.html

SOURCE Jazz Pharmaceuticals plc